Focus: Forest Devices is a Pittsburgh-based biotechnology company developing a portable EEG-based diagnostic device using machine learning to identify large vessel occlusions and stroke subtypes. The company operates primarily in neurology and cardiovascular segments.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Forest Devices to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Dominant revenue contributor at 73% of total, representing a mature SSRI in post-exclusivity decline with minimal growth potential.
Help build intelligence for Forest Devices
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Forest Devices's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Second-largest revenue source facing imminent loss of exclusivity, further pressuring portfolio economics.
Pre-launch combination analgesic with minimal commercial momentum or visibility.
Minimal revenue contributor in post-LOE status, representing legacy portfolio asset.
99 discontinued, 8 duplicate formulations not shown
No open positions listed yet.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moSource: USCIS H-1B Employer Data Hub